Therefore, solely targeting EGFR phosphorylation may not be sufficient to inhibit EGFR-mediated signaling in lung cancer without EGFR mutations, indicating that we do not fully understand EGFR signaling in lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.